Bruno Gallo
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $270,437 of the $313,203 with a category attached, or 86.3%. 47 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 38.5% of the total. Reporting peaked in 2019 at $121,464 and has fallen 100.0% since, to $29 in 2025. Among neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 832 payments — averaging $376.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$120K
- Adamas Pharmaceuticals, Inc.$82K
- Acadia Pharmaceuticals Inc$40K
- Acorda Therapeutics, Inc$38K
- Sunovion Pharmaceuticals Inc.$17K
- Abbott$7K
- plus $8K from 41 others
Across 15 payments — averaging $11,829 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$156K
- Boston Scientific$13K
- Abbott$9K
What the payments were for
- Consulting fees$18,0796%
- Speaking & faculty fees$270,43786%
- Travel & lodging$8,7683%
- Food & beverage$15,7285%
- Education$1920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$118,139
- GOCOVRI$80,698
- NUPLAZID$39,017
- INBRIJA$37,238
- APTIOM$16,496
- Infinity DBS Pulse Generators$3,278
- Libra and LibraXP DBS IPG$2,901
- NOURIANZ$1,709
- APOKYN$500
- INFINITY$432
- XEOMIN$176
- ASCLERA$176
- Neuromodulation Dspsbls and Accs$126
- LONHALA MAGNAIR$117
How this compares
$313,203 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Other neurology in Miami
- Diego Torres-RussottoMiami$652K
- Brad HerskowitzMiami$273K
- Flavia NelsonMiami$264K
- Corneliu LucaMiami$257K
- Kottil RammohanMiami$176K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.